| |
|
|
|
PLx Pharma Inc.  
|
|
3.77 -0.01 (-0%) |
10-19 15:59 |
|
Open: |
3.7022 |
Pre close: |
3.78 |
Target:
|
5.19
|
|
High: |
3.77 |
Low: |
3.61 |
Resistance:
|
4.44
5.10
|
|
Volume: |
403 |
Market Cap: |
33M |
Support:
|
3.38
2.81
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.74
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
3.94  |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
3.88 |
Stochastic Oscillator |
%K(14,3):
|
31.44 |
|
MA(250): |
5.04 |
%D(3): |
16.89 |
|
Average Volume(K) |
3-Month: |
801
|
52-Week |
High:
|
9.10 |
|
10-Days: |
178 |
Low: |
3.05 |
|
RSI |
RSI(14):
|
46.86 |
Change(%): |
-58.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.620 |
Return on Equity (ttm) |
-95.4 |
Shares Out. (M) |
8.74 |
|
EPS Est. Current Year |
-1.610 |
Return on Assets (ttm) |
-37.2 |
Shares Float (M) |
4.27 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
-0.15 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.460 |
Qtrly Rev. Growth |
-55.5 |
% Held by Institutions |
16.80 |
|
Forward EPS |
-1.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
28 |
|
Book Value (p.s.) |
5.040 |
EBITDA (p.s.) |
-0.415 |
P/E |
-2.33 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.75 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.19 |
P/S |
411872512.00 |
|
Operating Margin |
-2082.24 |
Levered Free Cash Flow
(M) |
-9.51 |
P/CF |
-2.50 |
|
|
|
|
|
|
